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Abstract
DNA microarray technology has been widely used to simultaneously determine the expression levels of thousands of genes.
A variety of approaches have been used, both in the implementation of this technology and in the analysis of the large amount
of expression data. However, several practical issues still have not been resolved in a satisfactory manner, and among the most
critical is the lack of agreement in the results obtained in different array platforms. In this study, we present a comparison of
severalmicroarrayplatforms[Affymetrixoligonucleotidearrays,customcomplementaryDNA(cDNA)arrays,andcustomoligo
arrays printed with oligonucleotides from three different sources] as well as analysis of various methods used for microarray
target preparation and the reference design. The results indicate that the pairwise correlations of expression levels between
platforms are relative low overall but that the log ratios of the highly expressed genes are strongly correlated, especially between
Affymetrix and cDNA arrays. The microarray measurements were compared with quantitative real-time-polymerase chain
reaction (QRT-PCR) results for 23 genes, and the varying degrees of agreement for each platform were characterized. We have
alsodevelopedandtestedadoubleampliﬁcationmethodwhichallowstheuseofsmalleramountsofstartingmaterial.Theadded
round of ampliﬁcation produced reproducible results as compared to the arrays hybridized with single round ampliﬁed targets.
Finally, the reliability of using a universal RNA reference for two-channel microarrays was tested and the results suggest that
comparisons of multiple experimental conditions using the same control can be accurate.
© 2004 Elsevier B.V. All rights reserved.
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1. Introduction
DNA microarray technology has become an im-
portant tool in biological investigations by allowing
researchers to measure the expression levels of thou-
sands of genes simultaneously (Brown and Botstein,
1999; Choi et al., 2001; Lockhart and Winzeler, 2000;
Schena et al., 1995). Generally, DNA microarrays are
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created in two basic forms: by DNA deposition or by
in situ synthesis of oligonucleotide arrays. Deposited
DNA materials can be in the form of polymerase chain
reaction (PCR)-ampliﬁed complementary DNAs (cD-
NAs), pre-synthesized oligonucleotides, or genomic
DNAs in the form of plasmids such as bacterial artiﬁ-
cial chromosomes (BACs). Fabrication of in situ syn-
thesized oligonucleotides by photolithographic masks
was pioneered by Affymetrix Inc. (Santa Clara, CA).
All these platforms employing cDNA or oligonu-
cleotides use unique target ampliﬁcation and labeling
methods (Dorris et al., 2002; Eberwine et al., 1992;
Feldman et al., 2002; Wang et al., 2000).
The availability of such multiple array platforms,
which may also differ in probe preparation methods
and array surface chemistry, raises the question of
cross-platform agreement in gene expression measure-
ments. Besides the many studies that have examined
in detail the performance characteristics of single plat-
forms [e.g., 50-mer oligonucleotides on glass (Kane
et al., 2000) and cDNA arrays (Yue et al., 2001)],
a number of comparative studies have been carried
out. In Kuo et al. (2002), corresponding measure-
ments from cDNA and Affymetrix GeneChip arrays
were reported to show poor correlation for samples
from human cancer cell lines; in Yuen et al. (2002),
Affymetrix and laboratory-developed cDNA arrays
were compared and concordant results were obtained
on a number of genes with known regulation, al-
though both platforms consistently underestimated the
fold changes. In a comparison study between spotted
70-mer oligonucleotide arrays and Affymetrix for hu-
man samples, correlation coefﬁcients of 0.8–0.9 were
obtained for differential expression ratios (Barczak
et al., 2003); similarly, between unmodiﬁed 70-mer
oligonucleotide arrays on glass slides and cDNAs,
a correlation coefﬁcient of 0.80 (Wang et al., 2003)
was observed. In Li et al. (2002), both sensitivity and
speciﬁcities for selected genes were found to be very
different between Affymetrix and commercial long
cDNA arrays, and Affymetrix arrays appeared to per-
form more reliably. In Tan et al. (2003), Affymetrix,
Agilent (cDNA probes) and Amersham (Codelink,
30-mer oligonucleotide probes) were shown to ex-
hibit considerable divergence, with correlations in the
range of 0.5–0.6 for both expression measurements
and log ratios. All these reports have provided some
answers as well as adding a barrage of new questions
on the reliability of data from different microarray
platforms.
In the present study, we systematically compared
three different microarray platforms constructed from
three different oligonucleotide sources (Affymetrix
MG-U74A array, a custom cDNA array, and custom
oligo arrays printed with oligonucleotides from three
different sources). Quantitative real-time RT-PCR
(QRT-PCR) on tens of selected genes was also per-
formed to conﬁrm the results obtained with each plat-
form. We carry out an extensive analysis of the data.
In addition to the correlation analysis on matched
genes for overall agreement, our analysis includes
estimation of coefﬁcient of variations through regres-
sion, examination of dynamic ranges, comparisons of
log ratios at different signal intensity levels, charac-
terization of systematic under-estimation of the ratios
relative to the RT-PCR results, and comparisons of
probes mapping to the same gene in a given platform.
In particular, the typical analysis by the Pearson cor-
relation coefﬁcient on the log ratios can be unstable,
depending heavily on the details of the ﬁltering crite-
ria and simply due to the inherent properties of ratios.
We therefore examine the correlations among the
platforms as a function of signal intensity. We also
suggest how the fold ratios should be modiﬁed for
each platform based on the extent of under-estimation
for log ratios.
DNA microarray hybridization using conventional
methods where mRNA or total RNA is labeled and
hybridized without ampliﬁcation is particularly chal-
lenging when only a small amount of RNA is avail-
able.Usingconventionallabelingmethods,even20g
of total RNA is often insufﬁcient. This can ultimately
lead to diminished signal intensity and thus introduce
a great deal of spot to spot variation. PCR methods
have been used to amplify signals (Iscove et al., 2002;
Livesey et al., 2000; Puskás et al., 2002). However, it
wasnotclearifthenumberoftranscriptsampliﬁedwas
proportional to the original copy numbers due to the
exponential ampliﬁcation nature of PCR itself. A lin-
ear ampliﬁcation method using T7 promoter has been
developed and popularly used in past years (Dorris
et al., 2002; Puskás et al., 2002; Wang et al., 2000).
As starting materials extracted from various experi-
ments become enormously scarce such as on the tens
of nanogram scale, the need for a more signiﬁcant am-
pliﬁcation method is required. Here, we have devel-P.J. Park et al. / Journal of Biotechnology 112 (2004) 225–245 227
oped and tested a double ampliﬁcation method which
allows the use of much smaller amounts of starting
material.
Furthermore, a consensus has not yet been reached
regarding the type of RNA reference sample most suit-
able for two color microarray experiments. Currently,
a universal standard RNA reference sample, which
combines total RNA from several cell lines, is avail-
able for use from Stratagene (La Jolla, CA) or BD Bio-
sciences Clontech (Palo Alto, CA). Nonbiased testing
using this universal standard reference will provide
researchers with meaningful information to incorpo-
rate in future microarray experimental plans. To see if
a standard for microarray RNA reference can be ap-
plied to research practice, a universal RNA reference
for microarrays was tested.
2. Materials and methods
2.1. Microarray fabrication
Amongst all arrays compared, only the Affymetrix
GeneChip array is currently commercially available.
The Affymetrix array used in this experiment was the
Murine Genome U74A Version 2 GeneChip. Each
gene represented on the Affymetrix array contains
twenty 25-mer probes encompassing 200–300bps de-
rived from the gene. The remaining arrays included in
our comparisons were all custom-designed arrays. The
cDNA array is a 16K array designed by our laboratory.
The cDNA clones are based on the RIKEN FAN-
TOM cDNA library (http://fantom.gsc.riken.go.jp)
and the PCR products were inkjet-printed by Agi-
lent Technologies (Palo Alto, CA). cDNA probes are
0.5–3kb in length where about 60% of the probes
represent full length transcripts. The 16K oligo array
includes 13,536 Operon (Operon Technologies Inc.,
Alameda, CA) designed and synthesized probes, and
2,304 Compugen (Compugen Ltd., Jamesburg, NJ)
designed and Sigma–Genosys (The Woodlands, TX)
synthesized probes. Oligo probes measure 70-mer
(Operon) and 65-mer (Compugen) in length and were
designed according to sequence, melting temperature,
and ATGC content. This 16K oligo array was also
inkjet-printed by Agilent Technologies. Lastly, a 10K
oligonucleotide set was separately purchased from
MWG (MWG Biotech Inc., High Point, NC) and
printed on CMT-GAPS Coated Slides (Corning Inc.,
Acton, MA) using a high-precision pin-spotting robot
(OmniGrid: GeneMachines, San Carlos, CA) to make
pin-spotted oligo arrays.
2.2. RNA samples
To evaluate the different array platforms and label-
ing techniques, mouse spleen and liver total RNAs
were purchased from Clontech and used as the com-
mon starting material. The distribution of arrays in-
volved in the study is as follows: 4 Affymetrix arrays
(2 each for liver and spleen), 12 cDNA arrays (3 for
liver versus spleen, single ampliﬁcation; 3 for liver
versus spleen, double ampliﬁcation; 3 each for liver
and spleen versus universal reference); and 12 oligo
arrays [3 for liver versus spleen (+1 with dye swap);
3 with aminoally labeling; 2 with fragmentation; and
3 pin-spotted]. QRT-PCRs were done on 23 genes.
2.3. Target preparation
2.3.1. cDNA arrays
First strand cDNA was synthesized by incubating
3g of total RNA with 1l of 100pmol/l T7-oligo
dT at 70 ◦C for 10min followed by incubation with
4lo f5 × RT buffer, 2l of 0.1M DTT, 1lo f
10mM dNTP, and 1l of 200U/l SuperScript II
(Invitrogen Life Technologies, Carlsbad, CA) at 42 ◦C
for 1h. Second strand cDNA synthesis began with
the addition of 30lo f5 × second strand buffer
(Invitrogen), 3l of 10mM dNTP, 4lo f1 0 U / l
Escherichia coli DNA polymerase I (New England
Biolabs Inc., Beverly, MA), 1lo f1 0 U / l E. coli
DNA ligase (NEB), 1lo f2 U / l of RNase H (In-
vitrogen), and 91l of nuclease-free water followed
by incubation at 16 ◦C for 2h. After incubation, 2l
of T4 DNA polymerase (5U/l) (Invitrogen) was
added to the mixture followed by 5min incubation
at 16 ◦C. The sample was immediately placed on ice
and then centrifuged brieﬂy prior to the addition of
7.5l of RNA digestion buffer (1N NaOH, 2mM
EDTA pH8.0) and the subsequent 10min incubation
at 65 ◦C. After the sample was cooled on ice, 160l
of 25:24:1 phenol:chloroform:isoamyl alcohol was
added to the mixture. The reaction was vortexed and
immediately transferred to a Phase Lock Gel tube
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trifugation at 12,000 × g. After centrifugation, 75l
of 7.5M ammonium acetate (−20 ◦C) and 500lo f
100% ethanol (−20 ◦C) were mixed with the upper
phase in a new 1.6ml tube. The sample was then
centrifuged immediately at 12,000rpm for 20min at
room temperature. The supernatant was removed and
the pellet was washed using 80% ethanol (−20 ◦C)
and 100% ethanol (−20 ◦C). The dried pellet was
then dissolved in 22l of nuclease-free water and
stored at −20 ◦C.
The day following cDNA synthesis, 16l of cDNA
was incubated with 24l of transcription mixture
(MEGAscript T7 Kit, Ambion Inc., Austin, TX);
consisting of 4lo f1 0 × reaction buffer, 4lo f
ATP solution, 4l of CTP solution, 4lo fG T P
solution, 4l of UTP solution, and 4l of enzyme
mix, at 37 ◦C for 4h. Immediately following incu-
bation, 2l of DNase I was added and the reaction
mixture was incubated at 37 ◦C for 15min. After in
vitro transcription, phenol extraction was performed
by mixing 100l of phenol:chloroform:isoamyl alco-
hol (25:24:1) with 100l of the cRNA mixture and
centrifuged for 30s at 12,000 × g. The mixture was
immediately transferred to a pre-spin Phase Lock Gel
tube and centrifuged for 5min at 12,000 × g. The
upper phase was removed with care and transferred
to a fresh tube. Phenol extracted cRNA was further
puriﬁed by using RNeasy Mini Kit (Qiagen Inc.,
Valencia, CA). Fluorescent target labelling was per-
formed by incubating 5g of ampliﬁed cRNA with
2lo f3g/l random hexamer primer at 70 ◦C for
10min. After primer denaturation, the reaction mix-
ture was incubated with 6lo f5 × ﬁrst strand buffer,
3l of 0.1M DTT, 0.6lo f5 0 × dNTP mix, 2lo f
SuperScript II RT, and 3l of 1mM Cyanine 3-dUTP
or 1mM Cyanine 5-dUTP (Amersham Biosciences,
Piscataway, NJ) at 42 ◦C for 2h. The reaction mix-
ture was then concentrated using Microcon YM-30
ﬁltering unit (Millipore, Billerica, MA).
Cyanine 3 or Cyanine 5 labelled cDNA were
combined with 2.5l of Mouse Cot-1 DNA (Invit-
rogen), 2.5l of deposition control target (Operon),
and 12.5lo f2 × hybridization buffer (Agilent).
The mixture was boiled for 3min and centrifuged at
12,000rpm for 3min. About 24l of the resulting
mixture was applied to the array and hybridized at
60 ◦C for 17h. After hybridization, the array was
washed several times with solution I (0.5× SSC,
0.01% SDS, and 1mM DTT in nuclease-free wa-
ter) and solution II (0.06× SSC and 1mM DTT in
nuclease-free water), respectively.
2.3.2. Oligo arrays
Fluorescent Linear Ampliﬁcation Kit (Agilent) was
used. Brieﬂy, both ﬁrst and second strand cDNA were
synthesized by incubating 3g of total RNA with 5l
of T7 Promoter Primer in nuclease-free water at 65 ◦C
for 10min followed by incubation with 4lo f5 × ﬁrst
strand buffer, 2l of 0.1M DTT, 1l of 10mM dNTP,
1l of 200ng/l random hexamers, 1l of 200U/l
MMLV-RT, 0.5lo f4 0U / l RNaseOUT, and 1lo f
Triton X-100 at 40 ◦C for 4h. Immediately following
cDNA synthesis, the reaction mixture was incubated
with4lof6.0mMCyanine-3-CTPor4lof4.0mM
Cyanine-5-CTP (Perkin-Elmer, Boston, MA), 20l
of transcription buffer, 8l of NTP mixture, 6lo f
0.1M DTT, 0.5l of RNaseOUT, 0.6l of inorganic
pyrophosphatase, 0.8l of T7 RNA polymerase, and
20.1lofnuclease-freewaterat40 ◦Cfor3h.Cyanine
3 or Cyanine 5 labelled cRNA were combined with
2.5l of Mouse Cot-1 DNA (Invitrogen), 2.5lo f
deposition control target (Operon), and 12.5lo f2 ×
hybridization buffer (Agilent). The mixture was boiled
for 3min and centrifuged at 12,000rpm for 3min.
About 24l of the resulting mixture was applied to
the array and hybridized at 65 ◦C for 17h. After hy-
bridization, the array was washed several times with
solution I (0.5× SSC, 0.01% SDS, and 1mM DTT in
nuclease-free water), solution II (0.25× SSC, 0.01%
SDS, and 1mM DTT in nuclease-free water), and so-
lution III (0.06× SSC and 1mM DTT in nuclease-free
water), respectively.
2.3.3. Affymetrix GeneChip
Double stranded cDNA was made as described in
cDNA arrays section. The cRNA labelling and hy-
bridization were processed as recommended by the
Bioarray High Yield RNA Transcript Labelling Kit
(Enzo Diagnostics Inc., Farmingdale, NY) protocol
and Affymetrix. Brieﬂy, cRNA was synthesized from
double stranded cDNA by incubating 10l of cDNA
with 4lo f1 0 × HY reaction buffer, 4lo f1 0 × bi-
otin labelled ribonucleotides, 4lo f1 0 × DTT, 4lo f
10× RNase inhibitor mix, 2lo f2 0 × T7 RNA poly-
merase, and 12l of nuclease-free water at 37 ◦C for
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ing RNeasy Mini Kit (Qiagen). cRNA was fragmented
by mixing 20g of cRNA (in 32l) with 8lo f5 ×
fragmentation buffer and 40l of RNase-free water.
The mixture was then incubated at 94 ◦C for 35min
and subsequently placed on ice. The hybridization
mixture was prepared by mixing 10g of fragmented
cRNAwith3.3lof3nMControlOligonucleotideB2
(Affymetrix), 10lo f2 0 × Eukaryotic Hybridization
Controls (bioB, bioC, bioD, cre) (Affymetrix), 2l
of 10mg/ml herring sperm DNA, 2l of 50mg/ml
acetylated BSA, 100lo f2 × hybridization buffer,
and lastly enough nuclease-free water to make a ﬁnal
volume of 200l. During array equilibration, the hy-
bridization mixture was heated to 99 ◦C for 5min in
a heat block followed by 5min incubation at 45 ◦C.
After incubation, the hybridization mixture was spun
at maximum speed in a tabletop microcentrifuge for
5min to remove any insoluble material. Appropriate
volume of the hybridization mixture was then added
to the probe array. The probe array was subsequently
hybridized at 45 ◦C, rotating at 60rpm, for 16h. After
hybridization, the probe array was washed using the
GeneChip Fluidics Station 400 (Affymetrix).
3. Scanning
After hybridization and washing, cDNA and oligo
arrays were scanned by the Agilent Scanner G2505A
(Agilent) while Affymetrix arrays were scanned by
the Agilent GeneArray Scanner (Agilent).
4. Double ampliﬁcation method
Single ampliﬁcation was performed as described in
cDNA arrays. First strand cDNA synthesis for the sec-
ond cycle of ampliﬁcation began by incubating the
ampliﬁed cRNA with 1lo f1g/l random primer
and sufﬁcient amount of nuclease-free water at 70 ◦C
for 10min. Then, it was incubated with 4lo f5 ×
ﬁrst strand buffer, 2l of 0.1M DTT, 1lo f1 0m M
dNTP, and 1lo f4 0 U / l RNase inhibitor at 42 ◦C
for 2min. Immediately afterwards, 1l of 200U/l
SuperScript II was added to the mixture and incubated
at 42 ◦C for 1h followed by incubation with 1lo f
2U/l RNase H at 37 ◦C for 20min. Before beginning
second strand cDNA synthesis, RNase H in the reac-
tion mixture was denatured by heating to 95 ◦C for
5min. Second strand cDNA synthesis began by incu-
bating the reaction mixture with 1l of 100pmol/l
T7-(dT)24 primer at 70 ◦C for 10min. It was then in-
cubated with 30lo f5 × second strand buffer, 3l
of 10mM dNTP, 4l of 10U/ml E. coli DNA poly-
merase and 91l of nuclease-free water at 16 ◦C for
2h. After incubation, 2l of T4 DNA polymerase
(5U/l) was added to the mixture followed by 15min
incubation at 16 ◦C. Double stranded cDNA product
was subsequently cleaned-up by ethanol precipitation.
In vitro transcription, labelling, hybridization, wash-
ing, and scanning steps were performed in the same
manner described previously for the cDNA arrays.
5. Quantitative real-time RT-PCR
Quantitative real-time RT-PCR was performed us-
ing GeneAmp 5700 Sequence Detector System (Ap-
plied Biosystems, Foster City, CA). The measurement
was normalized to an 18S ribosomal RNA control.
To measure the copy number of each transcript, PCR
ampliﬁed segment of each gene was cloned into
pGEM-Teasy (Promega Corp., Madison, WI) and then
cRNA was linearly ampliﬁed from NdeI-digested plas-
mid using MEGAscript T7 Kit (Ambion). cRNA was
measured with spectrophotometer DU640 (Beckman
Coulter Inc., Fullerton, CA) and a deﬁned amount of
cRNA was used to perform QRT-PCR. All QRT-PCR
measurements were replicated for each experiment
and the values were averaged.
6. Data analysis
The Affymetrix GeneChip information was ex-
tracted and data were computationally compared
using the Affymetrix Microarray Suite Version 5.0.
Genes ﬂagged NC/MI/MD (not changed/marginal
increase/marginal decrease) were removed. Genes
with two or more replicate values were averaged
and used for the analysis. The oligo and cDNA ar-
ray information were extracted using the Agilent
G2566AA Extraction Software Version A.6.1.1. Sev-
eral criteria were used to ﬁlter the oligo and cDNA
array data. Genes that were saturated, non-uniform,
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standard deviation of background) in either channel
were removed. After removing these spots from each
replicate, a triplicate ﬁlter was applied to the data
set. This ﬁlter involves the removal of genes that do
not have at least two or more replicate values, genes
where the replicate values differ in signs and have a
standard deviation above 0.5 (in log2 scale), or genes
where one replicate value shows more than two-fold
change while the other two replicate values show less
than two-fold change (unless the standard deviation
is less than 0.5 in log2). The remaining values were
averaged and used for the analysis.
7. Results and discussion
7.1. Within-platform variability
A basic property of a good microarray platform is
high reproducibility in repeated experiments. One way
to measure reproducibility within a platform is to mea-
sure a correlation coefﬁcient between the fold ratios
of all genes in replicate chips (all fold ratios or fold
changes hereafter refer to base 2 log ratios of spleen
and liver comparisons). When only non-competitively
hybridized arrays are considered, ﬁnding correlation
between the actual expression measurements is natu-
ral, but we consider the fold changes here for compar-
isons with two-channel cDNA arrays. A correlation
coefﬁcient of fold ratios can often be distorted due to
inaccurate high fold ratios generated by low-expressed
genes (further discussion to follow), and so we ﬁl-
ter the genes as described in Section 2. The resulting
correlation for within-platform reproducibility is high
for all platforms: the mean Pearson correlation coef-
ﬁcients are 0.96 for Affymetrix, 0.98 for cDNA, and
0.93 for oligos arrays. The only exception is the MWG
pin-spotted arrays. The pin-spotted array’s lower pre-
cision seemed to be due to its spotting method generat-
ing less uniform spots thus creating variations among
slides (Brody et al., 2002; Jenssen et al., 2002; Tran
etal.,2002).Theinkjetmethod,amoreadvancedspot-
ting method, provides more consistent spots (data not
shown).
To be sure that the high correlation coefﬁcients cor-
rectly reﬂect high reproducibility, we also examined
the variability in the single channel measurements (be-
fore taking ratios) as a function of signal intensity. A
useful measure of this is the coefﬁcient of variation
(CV), which is the standard deviation over the mean.
In Fig. 1, we plot the standard deviation as a function
of the mean, and ﬁt a curve using Locally Weighted
Scatterplot Smoothing (LOWESS) after a proper nor-
malization for all genes. For legibility, we only plot a
random 10% of the total points. It is clear from this
picture that Affymetrix platform appears to have the
smallest variability in repeated measurements. Linear
regression (without the intercept term) gives the slope
of 0.047, 0.12, and 0.29, for Affymetrix, cDNA, and
oligos, respectively [this is similar to what has been
observed in other studies; for example, a study by Yue
et al. (2001) has reported 12–14% CV for cDNAs].
While there is a large gene-by-gene variability as seen
in Fig. 1, that standard deviation is only 5–10% of
the total signal intensity on average is reassuring. We
note that the number of replicates was small and that
these are rough estimates. The general trend, however,
agrees with the rest of the analysis.
7.2. Inter-platform comparison
To make comparisons among different platforms,
genes with the same UniGene ID across all platforms
were matched. For Affymetrix and cDNA arrays, there
are many instances in which multiple probes in each
platform map to the same UniGene ID. For exam-
ple, in comparing Affymetrix and cDNA arrays, we
start with, after ﬁltering, 4545 out of 12,488 genes for
Affymetrix and 12,555 out of 16,273 genes for cDNA.
Between these, there are 1540 matched genes, involv-
ing 1762 Affymetrix probes and 2530 cDNA probes.
For multiple probes matching to the same gene, their
valueswereaveraged.(Theextentofagreementamong
these probes on the same chip that are supposed to
measure the same gene can give an indication of the
probequality;thisisanalyzedlater).InFig.2,weshow
the boxplots of the distribution of ratios for the genes
that are shared across all the platforms. Affymetrix ap-
pears to have the widest range, while cDNA and oligos
have smaller range. The overall pairwise correlations
between platforms are fairly low. Between Affymetrix
and cDNA (1540 genes in common), the Pearson cor-
relation coefﬁcient is 0.82; between Affymetrix and
oligos (668 genes), it is 0.66; and between cDNA and
oligos (752 genes), it is 0.47. The pairwise scatterplots
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Fig. 1. Standard deviation of intensity measurements as a function of mean intensity. A random 10% subset of the total points is plotted
and lowess curves are ﬁt for Affymetrix (black), cDNA (red), and oligos (green) platforms. Estimates of coefﬁcient of variation from
linear regression are 0.047, 0.12, and 0.29, respectively (these are rough estimates due to small sample size).
Fig. 2. Distribution of ratios for the common genes across all
the platforms (boxplots: the ﬁrst and third quartiles deﬁne the
box, with another line at the median; those values farther than
1.5 interquartile range (IQR) away from the box are considered
outliers and are plotted with circles) Affymetrix has the widest
dynamic range while the other two are comparable.
While these numbers appear to suggest unreliabil-
ity of at least one of the three platforms, it is possible
that these numbers are lower due to the noisy fold ra-
tios generated from low-intensity genes. In fact, one
of the common mistakes in analyzing cDNA arrays
has been to compute statistics on the ratios without ac-
counting for the intensities of the measurements from
which the ratios are derived. Low expressed genes
can produce log ratios of large magnitude by chance
and the Pearson correlation can be unduly inﬂuenced
by these outliers. A ﬁltering can eliminate many of
these non-expressed or low-expressed genes; however,
unless the ﬁltering is extremely stringent, the results
may still be misleading unless one accounts for the in-
tensity of the genes. This is clearly illustrated in Fig. 4.
For each of the three pairwise comparisons, we divide
the genes into 10 bins of equal size, in the order of
increasing averaged intensity ranks across platforms.
Thecorrelationcoefﬁcientisthencomputedseparately
for each bin. In Fig. 4, we see that the correlation co-
efﬁcient increases as the signal intensity increases. For232 P.J. Park et al. / Journal of Biotechnology 112 (2004) 225–245
Fig. 3. Pairwise comparison between platforms. For each of the three pairs (Affymetrix vs. cDNA, Affymetrix vs. oligo, cDNA vs. oligo),
log ratios of UniGene matched genes are plotted. The dotted line is the line with slope 1; the solid line is the linear regression line. The
correlation coefﬁcient is 0.82, 0.66, and 0.47, respectively. Oligo arrays appear to show poor concordance overall.
the Affymetrix versus cDNA comparison, for exam-
ple, which had a relatively high overall correlation, the
correlation is already above 0.6 in the lower quantiles
but it steadily increases to 0.92 for top 10% quantile.
More importantly, for the comparisons involving oli-
gos, we see a much more noticeable increase in corre-
lation, with more than 0.90 in the Affymetrix versus
oligos comparison in the top 10%. This plot clearly
indicates that even though the overall correlation may
Fig. 4. Correlation coefﬁcient as a function of intensity. For each
comparison, the matched genes are divided into 10 bins in the
order of their average signal intensity, and correlation coefﬁcient is
computed in each bin. Although the overall correlation coefﬁcient
may be low, a subset of genes with high intensity can in fact
have a good agreement. Solid, dashed, and dotted lines indicate
Affymetrix vs. cDNA, Affymetrix vs. oligo, and cDNA vs. oligo,
respectively.
be low, the log ratios of the highly expressed genes can
be strongly correlated and are like to be more reliable
estimates than is suggested by the overall correlation
coefﬁcient.
A major source in variation among the platforms
is simply the location of the probe sequences with
respect to the gene. The UniGene designation is
the result of a system for automatically partition-
ing GenBank sequences into a non-redundant set of
gene-oriented clusters; each UniGene cluster contains
several to many sequences that represent a unique
gene cluster. To compensate for these differences in
sequences, the probe sequences of about 150 liver
speciﬁc genes from each platform were veriﬁed to be
in an overlapping region of its counterpart, represent-
ing the same gene in another platform. Only the genes
represented in at least two platforms with probes
that are in overlapping regions of each other were
chosen for further analysis. The MWG pin-spotted
oligo set was eliminated in this comparison due to
the unavailability of its probe sequence information.
As predicted, the correlations between platforms us-
ing sequence-veriﬁed genes were higher (Fig. 5).
Affymetrix, cDNA, and Operon manufactured oligo
data were highly correlated to each other while the
Compugen-designed and Sigma–Genosys synthesized
oligo data shared less correlation with other platforms.
The comparison data for sequence-veriﬁed genes
in Table 1 provides clues regarding platform reliabil-
ity and probe quality. As shown in Table 1, compar-
ison with cDNA and Affymetrix arrays showed that
the Compugen or Operon oligos provided results that
were dissimilar to data from the cDNA and AffymetrixP.J. Park et al. / Journal of Biotechnology 112 (2004) 225–245 233
Fig. 5. Correlation between platforms on sequence veriﬁed genes. Probes in cDNA, oligo and Affymetrix chips, representing about 150
liver speciﬁc genes, were veriﬁed to be in overlapping regions of the transcript. The number on the bottom of each bar represents the
number of genes used to calculate that particular correlation coefﬁcient.
Table 1
Comparison of log ratio (base 2) among all platforms for sequence veriﬁed genes
Gene name cDNA Oligo Oligo source Affymetrix
Activator of basal transcription 0.37 0.18 Operon ND
Alpha 1 microglobulin/bikunin 5.10 4.42 Operon 8.38
Apolipoprotein H 5.83 ND Operon 7.75
Arginine-rich, mutated in early stage tumors 0.71 0.07 Operon ND
ATP-binding cassette, sub-family D (ALD), member 3 1.80 2.24 Operon 3.75
BCL2/adenovirus E1B 19 kDa-interacting protein 1, NIP3 4.14 3.91 Compugen 3.05
BCL2/adenovirus E1B 19 kDa-interacting protein 1, NIP3 4.14 4.29 Operon 3.05
CD1d1 antigen 1.35 0.30 Compugen 2.63
CD1d1 antigen 1.35 2.89 Operon 2.63
Creatine kinase, muscle 0.92 −0.40 Operon ND
Cytochrome P450, 4a10 ND 2.88 Operon 6.43
Cytochrome P450, steroid inducible 3a11 ND 4.94 Operon 6.33
Deiodinase, iodothyronine, type I 3.13 2.97 Operon 3.18
Glutathione S-transferase, theta 1 3.99 −0.16 Compugen 3.60
Glutathione S-transferase, theta 1 3.99 2.61 Operon 3.60
H2A histone family, member Y −0.55 −0.34 Operon −1.23
Insulin-like growth factor binding protein 7 −0.91 −1.68 Operon ND
Lectin, galactose binding, soluble 3 −2.05 −1.25 Compugen −2.43
Lectin, galactose binding, soluble 3 −2.05 −0.59 Operon −2.43
Programmed cell death 8 (apoptosis inducing factor) 2.04 1.60 Operon 1.25
Proline rich protein expressed in brain ND −2.23 Operon −1.10
RIKEN cDNA 1010001M12 gene 1.64 0.61 Operon 1.58
RIKEN cDNA 1300002A08 gene 2.75 2.01 Operon 2.03
RIKEN cDNA 2610022K04 gene 0.43 −0.02 Operon ND
Small inducible cytokine B subfamily (Cys-X-Cys), member 9 ND −0.13 Compugen −0.28
Small nuclear ribonucleoprotein D2 −0.04 −0.36 Operon −0.53
Solute carrier family 22 (organic cation transporter), member 1-like 3.76 0.44 Compugen 3.73
Solute carrier family 22 (organic cation transporter), member 1-like 3.76 1.75 Operon 3.73
Superoxide dismutase 1, soluble 3.04 2.11 Operon 2.25
ND: no data available.234 P.J. Park et al. / Journal of Biotechnology 112 (2004) 225–245
arrays. The inconsistency found in the oligo probes
reveals the importance of oligo design in obtaining
accurate gene expression readings. Further analysis
shows that the average signal intensity of the Compu-
gen set was lower than that of the Operon set (data
not shown). Since the same concentration (50M) of
Operon and Compugen probes were used for spotting,
a possible reason is that Compugen oligos contain an
added C6-amino group to the oligo terminus for ap-
plication to negative slide surface chemistry. This may
not be optimal for the Agilent’s slide surface chem-
istry used in this experiment.
Another way to test the performance of the probes is
to observe the extent of agreement between the probes
in a single platform that are designed to measure the
same gene. Higher quality probes would give more
consistent measurements on each chip, as most of the
variability arises from the lack of sufﬁcient sensitivity
and speciﬁcity. In Fig. 6, we show the variability in
the estimated ratios for the 10 genes with the largest
number of probes mapping to the same gene, for each
platform. As before, we expect the log ratios to be
more variable for the genes with low signal intensity.
We account for this by plotting the log ratios on the
y-axis and the average intensity for that gene on the
x-axis. For Affymetrix arrays, we see a good agree-
ment for the two genes with the highest intensity. Sev-
eral probes give relatively close estimates for the log
ratio. For the gene with the third highest average in-
tensity, the estimates are in much less agreement, with
estimates ranging from 0 to −7 in log ratios. With such
discrepancy, it is hard to make any conclusion about
that gene. In some cases, it is possible that the probes
are correctly detecting the varying numbers of tran-
scripts due to mechanisms such as alternative splicing.
For the rest of the genes, many probes give reasonably
good cluster of points; however, there is an outlier or
two in most cases. It appears that robust averaging,
e.g. taking the median of the values rather than the
mean, is needed to derive best results from the data.
Probes for the cDNA arrays are also variable in their
performance. The two with the highest mean intensity
show relatively large variability in the log ratio esti-
mates, while the third shows an excellent agreement.
On the oligo array, there are very few genes with mul-
tiple probes and it is difﬁcult to draw conclusions, al-
though there appears to be a large variability for the
few.
7.3. QRT-PCR
Toconﬁrmthemicroarraydata,23sequence-veriﬁed
genes were selected for quantitative RT-PCR analysis
(Table 2). In some cases, a particular gene was rep-
resented more than once on the cDNA array. From
Table 2, we see that multiple probes representing one
gene all show very similar expression levels to each
other, in spite of the fact that they were from different
cDNA fragments and derived from different clones.
In Fig. 7, we compared the fold changes observed
using QRT-PCR with each of the platforms for the
UniGene matched genes. When there were multiple
probes for the same gene, their values were averaged.
Operon and Compugen oligos are considered sepa-
rately and so few of the genes are missing in each of
the platforms.
To examine the dynamic range and the pres-
ence of any systematic bias, we ﬁt linear regression
(without the intercept term) for the data from each
platform as a function of the QRT-PCR values.
The coefﬁcients for the QRT-PCR terms are 0.76
(Affymetrix), 0.59 (cDNA), 0.42 (Oligos–Operon),
and 0.22 (Oligos–Compugen). All the coefﬁcients are
less than one, which indicates that QRT-PCR may be
most sensitive in detecting relative change. In other
words, cDNA, ink-jet printed oligo, and in situ oligo
arrays underestimate the real expression change as
detected by QRT-PCR, sometimes dramatically. This
observation is consistent with the one described in
Yuen et al. (2002). As was done in that study, it is
possible to rescale the fold ratios for better estimates
by the inverse of the slopes from the linear regres-
sion. The different amounts of scatter among the
measurements are also apparent in Fig. 7, providing
a measure of reliability for each platform. Among
the platforms, Affymetrix array is shown to have the
greatest dynamic range followed by the cDNA arrays,
as consistent with Fig. 2.
The correlation of ratios between each platform and
the QRT-PCR data are also calculated for the genes
in Table 2 (see Table 3). All platforms, with the ex-
ception of the Compugen oligo, showed high correla-
tion with the QRT-PCR result. Affymetrix most accu-
rately reproduced the QRT-PCR data with the high-
est correlation (0.93), while cDNA and Operon oligo
arrays also showed great similarity to the QRT-PCR
results with correlation coefﬁcients of 0.92 and 0.87,P.J. Park et al. / Journal of Biotechnology 112 (2004) 225–245 235
Fig. 6. Variations in the log ratios among the probes that measure the same gene. In each platform, the top 10 genes with the most number
of probes mapping to the same UniGene ID are identiﬁed; their log ratios are plotted (y-axis) at their average intensity (x-axis) to account
for intensity-dependent effects. The points along a vertical line belong to the same gene, and the tight clustering of these points indicates
good agreement between the probes for the same gene. The error bar notes one standard deviation away from the mean in each direction.
(A) Affymetrix; (B) cDNA; and (C) oligo.
respectively. The coefﬁcient for Compugen oligos is
only 0.64.
To observe the accuracy of measurements for each
gene, we display the data from all the platforms along
with the QRT-PCR in a matrix form in Fig. 8, arranged
using a hierarchical clustering method for clarity. In
Euclidean distance metric, closest to the QRT-PCR
measurements are those of Affymetrix, followed by
cDNA, Operon, and Compugen. Although Compugen
and Operon are both oligos, Operon is closer to cDNA
than it is to Compugen (the distances have been prop-
erly adjusted to account for the missing values). The
differences in the dynamic range can be easily seen
by the range of colors in each column.
We also successfully calculated the copy number
of each transcript per mouse liver cell or spleen cell2
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Table 2
QRT-PCR conﬁrmation of microarray data
Gene name UniGene cDNA Affy
GB ID Log ratioa Liver
intensity
Spleen
intensity
GB ID Log ratioa Liver
intensity
Spleen
intensity
Alpha 1 microglobulin/bikunin Mm.2197 AK004907 5.10 26502.8 782.1 X68680 8.38 26911.6 77.0
Diazepam binding inhibitor Mm.2785 AK018720 3.90 28451.6 1904.3 X61431 3.60 14198.0 958.0
AK008576 4.14 63135.4 3600.5
RIKEN cDNA 0710008N11 gene Mm.29141 AK009660 2.52 46894.0 8187.7 AA674669 2.18 7312.8 1647.4
AK003052 2.57 14050.9 2364.8
Glutathione S-transferase, theta 1 Mm.2746 AK002338 3.99 16525.3 1045.6 X98055 3.60 4389.3 327.4
RIKEN cDNA 1810009A06 gene Mm.29135 AK007389 −0.04 6897.6 7032.9 AI837853 −0.53 2326.9 3590.6
BCL2/adenovirus E1B
19kDa-interacting protein 1, NIP3
Mm.2159 AK014223 4.14 2861.0 165.0 AF041054 3.05 1048.9 125.9
Glutathione S-transferase, alpha 4 Mm.2662 AK019271 3.82 53665.0 3846.9 L06047 4.90 657.0 27.2
AK008189 3.82 53368.1 3791.1
AK008490 3.85 31636.8 2215.1
AK011177 4.02 48693.2 3000.4
AK010098 4.07 48687.2 2905.2
AK008400 4.07 56724.2 3408.7
AK011841 4.08 19011.0 1125.6
AK008193 4.20 64587.9 3552.9
Suppressor of Ty 4 homolog (S.
cerevisiae)
Mm.622 AK002990 −0.39 5201.7 6847.7 U96810 −1.33 266.7 620.5
Deiodinase, iodothyronine, type I Mm.2774 AK002549 3.13 939.4 112.7 U49861 3.18 125.1 15.4
Lectin, galactose binding, soluble 3 Mm.2970 AK008593 −2.05 3479.2 14487.1 X16834 −2.43 109.8 835.8
DNA-damage inducible transcript 3 Mm.7549 AV070098 −0.18 2301.3 2634.1 X67083 −3.10 48.9 399.1
Growth arrest and
DNA-damage-inducible, gamma
Mm.9653 AK007410 2.67 11008.0 1727.8 AF055638 1.50 875.2 309.4
BCL2/adenovirus E1B
19kDa-interacting protein 3-like
Mm.29820 AK013467 −1.40 22116.2 58244.9 AF067395 −2.25 575.4 2736.8
AK007920 −1.56 19020.5 56002.4
Cyclin-dependent kinase inhibitor 2C
(p18, inhibits CDK4)
Mm.1912 AK003933 −1.22 1421.9 3305.2 U19596 −1.25 303.9 722.8
NM 00767 −1.45 309.3 842.7
RAB17, member RAS oncogene
family
Mm.38889 AK009707 3.21 10097.7 1094.4 X70804 2.13 216.9 49.7
NM 008998 1.13 408.3 187.1
CDC28 protein kinase 1 Mm.3049 AK004101 −1.47 1304.7 3615.1 AB025409 −2.65 195.0 1223.6
AK011314 −2.05 2865.0 11866.2
Disintegrin metalloprotease (decysin) Mm.36742 AK008929 −2.65 5170.3 32428.7 AJ242912 −4.33 43.4 869.9
RNA binding motif protein, X
chromosome
Mm.28275 AK008618 −1.77 3904.2 13300.6 AJ237846 −3.50 26.4 298.7
C-type (calcium dependent,
carbohydrate recognition domain)
lectin, superfamily member 6
Mm.47384 AK020363 −2.74 2062.0 13808.1 AJ133533 −3.28 17.0 164.1P
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Mus musculus CD83 antigen (Cd83),
mRNA
Mm.57175 AV133938 −4.29 2337.1 45590.5 AI837100 −5.05 15.7 520.1
NM 009856 −4.44 1929.2 41752.1
Regulator of G-protein signaling 2 Mm.28262 NM 00906 −3.48 4956.5 55447.9 U67187 −4.88 15.3 447.5
Tnf receptor-associated factor 1 Mm.12898 BG064103 −2.89 1144.4 8504.7 L35302 −4.85 12.2 350.4
Mus musculus integrin alpha 6
(Itga6), mRNA
Mm.25232 NM 008397 −2.30 576.3 2836.7 X69902 −4.38 6.0 124.5
Gene name UniGene Oilgo RT-PCR
Source GB ID Log ratioa Liver
intensity
Spleen
intensity
Log ratioa Liverb copy
(2.5ng)
Spleenbcopy
(2.5ng)
Liver transcript
per cell
Spleen transcript
per cell
Body map
liver
From To From To
Alpha 1 microglobulin/bikunin Mm.2197 Operon D28812 4.42 47559.2 2412.3 9.61 2127917 2723 5107 8512 7 11 4
Diazepam binding inhibitor Mm.2785 Operon X61431 3.14 26591.0 3013.7 3.88 2756746 187666 6616 11027 450 751 1
RIKEN cDNA 0710008N11 gene Operon NM 023374 1.98 35208.5 8904.9 2.58 142586 23846 342 570 57 95 2
Glutathione S-transferase, theta 1 Mm.29141 Compugen NM 008185 −0.16 344.1 380.9 4.51 100616 4428 241 402 11 18 1
Operon X98055 2.61 3798.3 613.7
RIKEN cDNA 1810009A06 gene Mm.2746 Operon AK007389 −0.36 15916.9 20526.6 −0.99 50259 99816 121 201 240 399 1
BCL2/adenovirus E1B
19kDa-interacting protein 1, NIP3
Mm.29135 Compugen NM 009760 3.91 30813.1 2210.2 4.72 400750 15208 962 1603 36 61 1
Mm.2159 Operon AF041054 4.29 28705.6 1316.2
Glutathione S-transferase, alpha 4 Mm.2662 Operon L06047 2.78 8619.0 1166.1 3.38 65629 6310 158 263 15 25 1
Suppressor of Ty 4 homolog
(S. cerevisiae)
Mm.622 Compugen NM 009296 −0.19 802.1 914.2 −0.99 30687 60875 74 123 146 244 1
Deiodinase, iodothyronine, type I Mm.2774 Operon U49861 2.97 2585.5 296.9 6.84 31591 276 76 126 1 1 1
Lectin, galactose binding, soluble 3 Mm.2970 Compugen X16834 −1.25 1129.2 2682.2 −3.22 2372 22133 6 9 53 89 N/A
Operon X16834 −0.59 566.0 857.2
DNA-damage inducible transcript 3 Mm.7549 Operon X67083 −0.65 245.1 389.8 −2.31 4074 20269 10 16 49 81 6
Growth arrest and
DNA-damage-inducible, gamma
Mm.9653 Operon AF055638 1.39 1416.1 542.1 2.45 N/A N/A N/A N/A N/A N/A N/A
Compugen NM 011817 0.14 677.0 615.7
BCL2/adenovirus E1B
19kDa-interacting protein 3-like
Mm.29820 Compugen NM 009761 −0.31 478.2 593.4 −2.04 N/A N/A N/A N/A N/A N/A N/A
Operon AF067395 −1.38 2797.9 7275.9
Cyclin-dependent kinase inhibitor 2C
(p18, inhibits CDK4)
Mm.1912 Operon U19596 −0.40 946.7 1247.7 −2.63 N/A N/A N/A N/A N/A N/A N/A
Compugen NM 007671 −0.38 1373.0 1790.4
RAB17, member RAS oncogene
family
Mm.38889 Operon X70804 0.73 483.2 290.4 7.91 N/A N/A N/A N/A N/A N/A N/A
Compugen NM 008998 0.39 427.8 326.3
CDC28 protein kinase 1 Mm.3049 Compugen NM 016904 −1.59 1920.9 5787.6 −3.51 N/A N/A N/A N/A N/A N/A N/A
Operon AB025409 −1.40 1146.9 3018.22
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Table 2 (Continued)
Gene name UniGene Oilgo RT-PCR
Source GB ID Log ratioa Liver intensity Spleen
intensity
Log ratioa Liverb copy
(2.5ng)
Spleenb copy
(2.5ng)
Liver transcript
per cell
Spleen transcript
per cell
Body map
liver
From To From To
Disintegrin metalloprotease (decysin) Mm.36742 Compugen NM 021475 −1.39 2103.1 5508.6 −2.75 N/A N/A N/A N/A N/A N/A N/A
Operon AJ242912 −1.46 653.2 1797.1
RNA binding motif protein, X
chromosome
Mm.28275 Operon AJ237846 −0.76 538.8 912.5 −2.34 N/A N/A N/A N/A N/A N/A N/A
C-type (calcium dependent,
carbohydrate recognition domain)
lectin, superfamily member 6
Mm.47384 Operon AJ133533 −1.94 1226.9 4715.5 −3.40 N/A N/A N/A N/A N/A N/A N/A
Operon NM 011999 −2.86 414.4 3007.7
Compugen NM 011999 0.22 364.9 313.0
Mus musculus CD83 antigen (Cd83),
mRNA
Mm.57175 Compugen NM 009856 −2.91 2554.2 19197.5 −5.46 N/A N/A N/A N/A N/A N/A N/A
Operon NM 009856 −2.58 2532.6 15151.4
Regulator of G-protein signaling 2 Mm.28262 Compugen NM 009061 −0.37 343.9 445.6 −3.30 N/A N/A N/A N/A N/A N/A N/A
Operon U67187 −2.48 1003.2 5606.8
Tnf receptor-associated factor 1 Mm.12898 Compugen NM 009421 −1.05 752.9 1558.7 −6.95 N/A N/A N/A N/A N/A N/A N/A
Operon L35302 −0.65 509.3 799.3
Mus musculus integrin alpha 6
(Itga6), mRNA
Mm.25232 Compugen NM 008397 −0.52 367.3 527.0 −5.36 N/A N/A N/A N/A N/A N/A N/A
Note: Liver or spleen intensity displayed is an average of the three replicates’ red (liver) or green (spleen) processed intensity (after dye normalization and background subtraction).
a Changes in gene expression are reported as log2 ratio.
b The yield of total RNA from 1 × 106 cells was estimated to contain between 6 and 10g of total RNA.P.J. Park et al. / Journal of Biotechnology 112 (2004) 225–245 239
Table 3
Correlations among platforms and QRT-PCR results using QRT-PCR conﬁrmed genes
QRT-PCR Affymetrix cDNA Oligo (Operon) Oligo (Compugen)
QRT-PCR 0.93 0.92 0.87 0.64
Affymetrix 0.93 0.96 0.94 0.66
cDNA 0.92 0.96 0.96 0.71
Oligo (Operon) 0.87 0.94 0.96 0.75
Oligo (Compugen) 0.64 0.66 0.71 0.75
(Table 2) using the QRT-PCR approach. The lowest
number of transcripts calculated in the spleen data
was 1 copy per cell, conﬁrming the high sensitivity
of the microarray technique. In theory, the level of
probe binding in the array predicts the copy number
of the gene probe. We tried to ﬁnd if there is a linear
relationship between the hybridization intensities and
gene copy numbers calculated by QRT-PCR. How-
ever, we could not ﬁnd any clear relationship between
them. Our result also indicates that the copy number
Fig. 7. QRT-PCR measurements vs. each platform for UniGene matched genes. The dotted line is the line with slope 1; clustering around
this line would indicate a good agreement with the QRT-PCR. The linear regression coefﬁcients are 0.76 (Affymetrix), 0.59 (cDNA), 0.42
(Oligos-Operon), and 0.22 (Oligos-Compugen), showing that arrays generally underestimate the fold changes by varying amounts.
was better predicted by Cyanine-5 (Red–Liver) sig-
nal intensity than the Cyanine-3 (Green–Spleen) sig-
nal intensity (data not shown). Primer sequences used
in the QRT-PCR are shown in Table 4.
A human and mouse gene expression database,
known as BodyMap (http://bodymap.ims.u-tokyo.ac.
jp/), provides abundance information for each tran-
script in different parts of the body (Sese et al., 2001).
It is based on ESTs collected from non-biased cDNA
libraries. However, the rough estimate of the mRNA240 P.J. Park et al. / Journal of Biotechnology 112 (2004) 225–245
Fig. 8. Gene-by-gene comparison of QRT-PCR data with data from other platforms. Affymetrix and RT-PCR show the closest agreement.
Hierarchical clustering was used only for the purpose of rearrangement; white space indicates missing values.
composition of mouse liver source was quite different
from our QRT-PCR and array experimental results
(Table 2). This emphasizes that such a study of pop-
ulation by sequencing of cDNA is prone to errors
originating from cloning ﬂuctuation.
7.4. RNA fragmentation
Another factor that enhances the dynamic range is
RNA fragmentation. We compared arrays hybridized
with fragmented and un-fragmented RNA probes on
oligo chips and found that RNA fragmentation no-
tably magniﬁes the binding sensitivity. Nearly 89% of
genes, showing a two-fold regulation in the same di-
rection of both fragmented and un-fragmented RNA
hybridized arrays, exhibit greater dynamic range af-
ter RNA fragmentation, increasing an average of 0.90
log2 ratio. However, fragmented RNA hybridized ar-
rays still correlate highly with un-fragmented arrays
(r = 0.90), showing that RNA fragmentation affects
only the probe binding sensitivity and not the overall
binding pattern.
7.5. Double ampliﬁcation
Recently, Richter et al. (2002) systematically eval-
uated and compared ﬁve different principles for
the synthesis of ﬂuorescently labeled targets for
microarray: direct labeling, T7 RNA polymerase
ampliﬁcation, aminoallyl labeling, hapten-antibody
enzymatic labeling, and 3DNA. Among them, the
most accurate and sensitive method was proven to be
the linear T7 RNA polymerase-mediated ampliﬁca-
tion, the major technique used for target preparation
in our experiments. Although the target prepara-
tion methods used here for the cDNA, oligo, and
Affymetrix GeneChip arrays are slightly different
from one another, they all fundamentally use the
T7 ampliﬁcation method and all showed comparable
results.P.J. Park et al. / Journal of Biotechnology 112 (2004) 225–245 241
Table 4
Primer sequences used in the QRT-PCR
UniGene ID GenBank ID Sequence (5 →3 ) Amplicon size (bps)
Mm.2197 X68680 Forward GAATATGCCATTTTCCTTACCAAGA 126
Reverse CAGGGCCACATCCTTGAACT
Mm.2785 X61431 Forward CCAACTGATGAAGAGATGCTGTTC 141
Reverse GGAAGTCCCTTTCAGCTTGTTC
Mm.29141 NM 023374 Forward TGGATTCTACTTTAACCTTCCGAAGA 148
Reverse TGTGGAAGAGGGTAGATTTTGGA
Mm.2746 X98055 Forward CATACGGGCCTTCGGAGAA 105
Reverse CAACGTGGCTGCCAGTGTT
Mm.29135 AK007389 Forward ACAACACGCAAGTGCTCATTAACT 123
Reverse TGGGAACCTCAGTCCACATCT
Mm.2159 AF041054 Forward GCTACTCTCAGCATGAGAAACACAA 143
Reverse GTCAGACGCCTTCCAATGTAGAT
Mm.2662 L06047 Forward ATCGATGGGATGATGCTGACA 121
Reverse GGGTGCCATCTGCATACATGT
Mm.622 NM 009296 Forward TGACTGCACCAGCTCTTCATTT 124
Reverse ACCAGTGACGGACACAGCATAT
Mm.2774 U49861 Forward TCTCAGGACAGAAGTGCAACATCT 136
Reverse GAGGCAAAGTCATCTACGAGTCTCT
Mm.2970 X16834 Forward CACAATCATGGGCACAGTGAA 138
Reverse TCCTGCTTCGTGTTACACACAAT
Mm.7549 X67083 Forward TCCAGAAGGAAGTGCATCTTCATA 109
Reverse CTGGACACCGTCTCCAAGGT
18S rRNA X00686 Forward GTAACCCGTTGAACCCCATT 151
Reverse CCATCCAATCGGTAGTAGCG
We studied double linear ampliﬁcation method and
tested the precision of single versus double ampliﬁca-
tion. Single T7 ampliﬁcation requires 1–3 g of total
RNA and demands about 3 days of work while dou-
ble ampliﬁcation requires 100 ng of total RNA and
takes about 4 days. To determine if there is any dif-
ference in the size distribution of the ampliﬁed cRNA
populations from single versus double ampliﬁcation,
the ampliﬁed cRNA products after a single or dou-
ble round of ampliﬁcation were measured by Agilent
Bioanalyzer (Agilent) (Fig. 9). Total spleen or liver
RNA was ampliﬁed using the single or double am-
pliﬁcation method for cDNA arrays. Results from the
Bioanalyzer show that double ampliﬁed cRNA con-
tains a higher percentage of shorter RNA compared to
the cRNA population generated from a single ampli-
ﬁcation. This phenomenon was repeatedly observed
through several attempts (data not shown).
To determine the adequacy of the protocol, we com-
pared the data from double ampliﬁcation sample to
those from a single ampliﬁcation sample. Using the
same ﬁltering scheme for the triplicates as before, we
ﬁnd the Pearson correlation to be 0.97, using 68% of
the data points that passed the ﬁlter (Fig. 10). As be-
fore, because the correlation is computed on the ra-
tios, we may get a distorted number due to high ratios
from low-intensity genes. When we bin the data points
into three groups according to their intensity, the cor-
relations are, from the low to high intensity values,
0.90, 0.97, and 0.99 (Fig. 11). This demonstrates that
the values from double ampliﬁed sample are in good
agreement with those of the single ampliﬁed sample,
especiallywhenthemeasurementsaredonewithrepli-
cates.
It is also of interest to measure reproducibility of
the slides within a protocol. Without a large number242 P.J. Park et al. / Journal of Biotechnology 112 (2004) 225–245
Fig. 9. RNA quality of single and double ampliﬁcation method.
Total spleen and liver RNAs were ampliﬁed using 1st (single) and
2nd (double) round ampliﬁcation method. RNA length was mea-
sured using the Bioanalyzer. Purple line shows the standard marker
displaying the length of the RNA at each peak by nucleotides (nt).
Green line represents RNA made from single ampliﬁcation while
the blue line shows the RNA made from double ampliﬁcation.
Fig. 10. Single vs. double ampliﬁcation. The Pearson correlation
coefﬁcient is 0.97. The dotted line is the line with slope 1. Overall,
there is good agreement between the two protocols.
of replicates, it is obviously difﬁcult to accurately as-
sess the reproducibility. As a rough estimate using the
three replicates, we ﬁnd the correlation between chips
to be 0.98 ± 0.007 for single ampliﬁcation and 0.91 ±
0.022 for double ampliﬁcation (0.93 ± 0.023 between
them). The correlations are lower in general here com-
pared to before because we did not use the information
across replicates to ﬁlter out unstable measurements.
It appears that the double ampliﬁcation achieves lower
reproducibility, as expected. We note again that these
numbers are preliminary, as a single chip can distort
these numbers. Overall, the additional round of ampli-
ﬁcation does lower the reproducibility of the log ra-
tios, but its effect on the precision of the double ampli-
ﬁcation method seems relatively small, as compared
to the single ampliﬁcation method. These results sug-
gest that the double ampliﬁcation method may be used
when the amount of total RNA available is scarce.
7.6. Universal reference
A consensus has not been reached regarding
the type of RNA reference sample that is best for
two-color microarray experiments, even though adopt-
ing a standard for microarray RNA reference as well
as data format will improve research practice (Dudley
et al., 2002; Holloway et al., 2002). For standardiza-
tion and annotation of expression data, the MGED
(http://www.mged.org, Microarry Gene Expression
Data) project aims to address standards for data format
(Spellman et al., 2002). In addition, many public gene
expression data repositories, such as Gene Expression
Omnibus (http://www.ncbi.nlm.nih.gov/geo/) and Ar-
rayExpress (http://www.ebi.ac.uk/arrayexpress/), have
been launched for convenient public dissemination of
gene expression data.
A de facto universal reference RNA may be helpful
in interpreting results among experiments and be-
tween laboratories, especially when massive microar-
ray data are analyzed. There are several commercial
suppliers of RNA reference, so-called ’Universal
Standard’, including Stratagene and Clontech. We
tested Stratagene’s Universal Mouse Reference RNA,
which is made up of 11 different cell lines for broad
gene coverage.
To compare the direct two-dye measurement with
using the universal reference, we plot in Fig. 12 the
ratios from the standard spleen/liver hybridizationP.J. Park et al. / Journal of Biotechnology 112 (2004) 225–245 243
Fig. 11. Single vs. double ampliﬁcation as a function of intensity. The points in Fig. 10 are divided into three bins according to a measure
of their average intensity. The three scatter plots correspond to the three bins. For the high-intensity genes (on the right), the agreement
is excellent, with less scatter around the line of slope 1.
against the ratios derived from spleen/reference and
liver/reference hybridizations. We ﬁnd that the corre-
lation is fairly high, at 0.93. A total of 9910 (94.8%)
out of 10,457 genes have a standard deviation of less
than 0.5 (log2) while only 75 elements (0.7%) have
a standard deviation of equal or above 1 (log2). This
indicates that the hybridizations in a reference design
can give ratio estimates similar to those obtained by
direct comparisons.
We do note, however, that there appears to be a
small number of genes for which the two ratios are
very different. In particular, there is a cluster of points
for which the standard two-dye gives the log ratio
Fig. 12. Log ratios from direct comparison (‘standard’) compared
to those from indirect comparison using universal reference. The
agreement is fairly good, with correlation coefﬁcient of 0.93.
(base 2) of about −3 and the common reference ap-
proach gives the log ratio of about 2. We have ver-
iﬁed that this cluster is not due to the instability of
ratios generated by low intensity signals. When these
30 or so probes are examined, they were all found to
correspond to hemoglobin alpha or beta or beta-like
chains (Hba-a1, Hbb-b1, and Hbb-bh1) mapping to
only three UniGene clusters, along with some unan-
notated ESTs. One possible explanation for this clear
and strong disagreement is the dye bias effect. It is
well known that a small fraction of the probes do not
get tagged by either the Cy3 or Cy5 labels, and that
dye–swapped replicates are needed to average out this
effect. When the universal reference was used, both
spleen and liver were tagged with the same dye, thus
lessening the dye bias, whereas the direct compari-
son approach was done in replicates but without the
dye–swap correction. We suspect that dye–swap cor-
rected values for direct comparison would be more in
agreement with the common reference samples. The
common reference design could still give a wrong ra-
tio if spleen and liver both do not respond to the same
dye used, but this bias is less likely to lead to false pos-
itives than if different dyes are used. Hence, using the
common reference may be advantageous in this case.
While some caution is needed, the result overall is
encouraging and suggests that multiple comparisons
of experimental conditions by using a common con-
trol can be accurate and can enhance sharing of array
information within the research community. However,
there might be unavoidable biases introduced by using
this universal standard. Therefore, using the reference
design may not be preferable when the experiment in-244 P.J. Park et al. / Journal of Biotechnology 112 (2004) 225–245
volves regulation of a small portion of the genes, and
thus requires a very sensitive measurement.
From this data set, we could also test a different
speculation. Some researchers have suggested that the
amountofcDNAsspottedonthearrayislargeenough,
away from the saturation point, and that it may be
possible to use cDNAs as a single channel array. We
therefore examined the reproducibility of signal from
the universal reference sample when the co-hybridized
samples are different. Our analysis suggests that the
speculation may indeed be reasonable. Using all the
data points on each array, we ﬁnd that the average cor-
relation among the universal reference channels with
the same second channel (either spleen or liver) is
0.97 ± 0.014. On the other hand, the average correla-
tion between the pairs of arrays in which the second
channels are different is 0.95 ± 0.012. The Spearman
correlations are also high at 0.97 for both. This means
that the second channel has a negligible effect on the
signal of the ﬁrst channel in terms of correlations. If
a ﬁlter had been applied for saturation and other ar-
tifacts, the correlation would have been higher. If the
same analysis is carried out on the spleen and the liver
channel, the difference is 0.96 for the within-group
and 0.68 for between groups, as expected. The fact
that the effect of the second sample hybridized on the
same array is very small indicates that the two chan-
nels may be independent to a large extent. As long as
saturated points are monitored and ﬁltered out, it may
be possible to essentially perform two separate exper-
iments on a single cDNA array.
7.7. Conclusions
The comparison of the three platforms gives a
mixed result. By most measures, the agreement be-
tween Affymetrix and cDNA arrays seems to be fairly
good and reproducible. However, the oligo arrays in
many cases do not give a concordant result. We have
noted that highly expressed genes give fairly similar
results in all cases and that combining unstable log
ratios from low expressed genes with other genes
can lead to somewhat misleading result. Probes with
overlapping sequences give a higher correlation as
expected. We also examined the differences between
the array data and the QRT-PCR data for a large
number of genes. Compared to the QRT-PCR values,
we found the differences to be small to substantial
for Affymetrix, cDNA, Operon oligo, and Compugen
oligo arrays, in that order, both in linear correlation
and in the extent of under-estimation of the log ratios.
We also examined other methods in the microar-
ray experiments. The printing method is crucial in
maintaining consistent spot form from array to array
and in minimizing variation among signal intensities:
inkjet printing approaches apparently provide less spot
to spot and chip to chip variability than pin-spotting
methods. The result from the double ampliﬁcation
data suggests that this method can be used reliably
for future microarray experiments especially when the
amount of total RNA is scarce. Finally, the results
from the universal standard data appear to support the
use of universal reference on microarray experiments
for enhancing the sharing of array information within
the research communities.
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